新药的费用由谁来支付？
Who's paying for new drugs?
作者信息
Oldham R K
机构信息
Biological Therapy Institute, Franklin, Tennessee 37064.
出版信息
Nature. 1988 Apr 28;332(6167):795. doi: 10.1038/332795a0.
DOI:10.1038/332795a0
PMID:3282177
Abstract
Direct payment by patients for treatment with drugs still in development is the subject of controversy. The matter goes deeper than it might first appear.
摘要
患者直接支付用于仍在研发中的药物的治疗费用，这一问题颇具争议。其涉及的问题比初看起来更为深入。
Zotero 插件